Clincosm LogoSign in Get a demo

MNO: Correlation OF SpO2/FiO2 RATIO WITH PaO2/FiO2 RATIO IN ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) PATIENTS IN THE ICU OF H. ADAM MALIK HOSPITAL

Sponsor
RS H Adam Malik (Other)
Overall Status
Completed
CT.gov ID
NCT06109168
Collaborator
(none)
29
Enrollment
1
Location
3
Actual Duration (Months)
9.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

to apprehend the relation of SpO2/FiO2 to PaO2/FiO2 in ARDS patients

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Actual Enrollment :
    29 participants
    Observational Model:
    Cohort
    Time Perspective:
    Cross-Sectional
    Official Title:
    Correlation OF SpO2/FiO2 RATIO WITH PaO2/FiO2 RATIO IN ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) PATIENTS IN THE ICU OF H. ADAM MALIK HOSPITAL
    Actual Study Start Date :
    Jun 1, 2023
    Actual Primary Completion Date :
    Aug 31, 2023
    Actual Study Completion Date :
    Sep 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Correlation OF SpO2/FiO2 RATIO WITH PaO2/FiO2 RATIO IN ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) PATIENTS IN THE ICU OF H. ADAM MALIK HOSPITAL [June - August 2023]

      ICU patients

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • ARDS patient

    • intubarted patient

    Exclusion Criteria:
    • Cardiac congenital disorder

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 RSUP H. ADam Malik Medan SUmatera UTara Indonesia 20222

    Sponsors and Collaborators

    • RS H Adam Malik

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Agus pramono, MD, RS H Adam Malik
    ClinicalTrials.gov Identifier:
    NCT06109168
    Other Study ID Numbers:
    • 536/KEPK/USU/2023
    First Posted:
    Oct 31, 2023
    Last Update Posted:
    Oct 31, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Respiratory Distress Syndrome
    Respiratory Distress Syndrome, Newborn
    Acute Lung Injury

    Study Results

    No Results Posted as of Oct 31, 2023